The Bowel Management Systems Market Size was valued at USD 1.6 Billion in 2022 and is projected to grow from USD 1.66 Billion in 2023 to USD 2.19 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.60% during the forecast period (2023 - 2032). The increasing availability of technically advanced solutions for management of bowels and growing geriatric population are market drivers expediting the market’s expansion.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
In February 2024, Coloplast introduced Peristeen® Light, a product designed specifically for individuals suffering from gastrointestinal issues. The newly developed transanal irrigation device is specifically designed to assist individuals experiencing difficulties with defecation or fecal incontinence. Approximately 10-15% of the global population is believed to experience chronic constipation, while 6% face the challenge of faecal incontinence. Both conditions can lead to physical discomfort and mental suffering. While transanal irrigation treatment can be beneficial, many patients have significant challenges in accessing and receiving this treatment, resulting in a large number of individuals being untreated. Certain patients may not have symptoms that are deemed sufficiently severe, while others may feel overwhelmed by the available treatments and products, which can often result in social isolation. Transanal irrigation is a thoroughly researched and efficacious treatment, although numerous obstacles persist, impeding individuals from accessing appropriate care. Peristeen Light aims to eliminate obstacles and provide access to treatment, thereby enhancing individuals' quality of life. Peristeen Light is specifically engineered to provide alleviation. The device is a portable, small-capacity transanal irrigation instrument that introduces water into the rectum, facilitating the removal of feces from the lower part of the intestine. Peristeen Light is created using the knowledge gained from 20 years of experience with Coloplast's Peristeen Plus, a transanal irrigation device used often. The Peristeen Light system is designed to be user-friendly and straightforward, with a simple two-step assembly process. It allows for a seamless insertion into the rectum using a gentle and flexible catheter.
In October 2023, Eli Lilly and Company (NYSE: LLY) received approval from the U.S. Food and Drug Administration (FDA) for Omvoh™ (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL). This is the first and only drug that targets interleukin-23p19 (IL-23p19) and is used to treat adults with moderately to severely active ulcerative colitis (UC). Omvoh is a unique medication for UC that specifically targets the p19 component of IL-23, a key factor in UC-related inflammation. The permission was granted based on the findings from the LUCENT program, which involved two Phase 3 clinical trials. These trials were randomized, double-blind, and placebo-controlled. The first trial, called UC-1, lasted for 12 weeks and focused on induction. The second trial, called UC-2, lasted for 40 weeks and focused on maintenance. The medication was administered continuously for a total of 52 weeks. Every patient enrolled in the LUCENT program had previously undergone treatments, such as biologic therapy, which proved ineffective, ceased to be effective, or were not tolerable.
The rise in the geriatric population and increasing awareness regarding bowel management is driving Market CAGR for bowel management systems. The market has been expanding due to an aging population and increased knowledge of bowel management. Additionally, the launch of technologically improved items is anticipated to accelerate market expansion. For instance, the Eclipse system was introduced by Pelvalon, a Biodesign program at Stanford University, as a cutting-edge non-surgical solution for women who are losing control of their bowels.
An aging globe analysis estimates that in 2015, out of 7.3 billion people globally, 617.1 million, or 8.5% were 65 or older. The number of senior individuals will probably increase by more than 60% in just 15 years. Fecal incontinence is now significantly more likely to occur as people age. Bowel incontinence affects 6.0% of women under 40 and escalates to 15.0% of older women, according to the International Foundation for Gastrointestinal Disorders. Additionally, bowel incontinence affects 6.0–10.0% of men, and its prevalence rises with age.
According to WHO, the majority of developed nations currently have life expectancies that are above 80 years. In the elderly population, incontinence is associated with several interrelated variables, such as chronic illnesses including stroke and disease, impairment of mobility, and cognitive decline Thus, driving the Bowel Management Systems Market revenue.
The Market segments of Bowel Management Systems, based on product includes irrigation systems, nerve modulation devices (NMD), colostomy bags, and other products and Accessories. Colostomy bags held the biggest market share as a result of growing public knowledge of their availability and advantages. Additionally, it is expected that the market would expand throughout the anticiapted years, beacuse of well-resatblished regions with organized reimbursement systems for colostomy goods.
The Bowel Management Systems Market segmentation, based on patient type, includes Adult patients, and Pediatric patients. The greatest market was the adult market. Over the course of the forecast, significant growth is anticipated. The high spread of fecal incontinence across adults can be blamed for this rise. It affects around 1 in 12 adults, or approximately 18 million people, in the United States, making it a common illness among adults. Around 10% of the population suffers from fecal incontinence, according to BMJ Publishing Group.
The Market segmentation of Bowel Management Systems, based on end-user, includes Home care, Hospitals, and Ambulatory surgery centers. The market was driven by the home care segment. During the forecast period, it is most expected to experience the fastest increase. The increasing use of bowel management products in home care settings is to blame for the segment's domination.
Figure 1: Bowel Management Systems Market, by End-User, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. Due to the increased rate of fecal incontinence and the growing senior population, Asia Pacific is predicted to experience the quickest growth during the projection period. Furthermore, the market is anticipated to be extended by the enormous unmet clinical requirements and the urgent need for better therapy.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: Bowel Management Systems Market Share By Region 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
North America Bowel Management Systems Market accounts for the second-largest position in the market. One of the main elements promoting the region's growth is the increased acceptance rate of bowel management systems, which is combined with patient awareness, a well-established healthcare infrastructure, and the high acceptability of modern goods. Further, the US market of Bowel Management Systems held the largest market share, and the Canada Bowel Management Systems Market was the quickest-growing market in the North American region
The Europe Bowel Management Systems Market is anticipated to expand at the quickest CAGR. This is due to the presence of a well-established healthcare infrastructure and leading market players. Moreover, China market of Bowel Management Systems held the fastest CAGR, and the India market of Bowel Management Systems was the quickest-growing market in the Asia-Pacific region.
Leading market players are investing largely in research & development-related activities to extend their product/service lines, which will aid the market of Bowel Management Systems, to grow faster. Market leaders are also adopting a range of strategies to expand their worldwide position, with important market developments including new product launches & developments, contractual agreements among companies with complementary service lines, mergers & acquisitions, increased investments, & collaboration with other organizations having complementary products and services. To grow in a competitive and rising market climate, the Bowel Management Systems industry needs to offer cost-efficient products.
Producing locally to cut operational expenses is one of the prime business strategies used by manufacturers in the Bowel Management Systems industry to benefit clients and increase the market sector. In recent years, the Bowel Management Systems industry has served with some of the key perks of medicine. Major players in the Bowel Management Systems Market, including Coloplast, Medtronic Inc., 3M, B.Braun, C.R. Bard, Consure Medical, Cogentix Medical, Aquaflush Medical Ltd., Axonics Modulation Ltd., ConvaTec and others are attempting to increase market growth via investing in research and development operations.
Medical technology and pharmaceutical goods are developed, produced, and distributed by B. Braun Melsungen AG (B. Braun), in addition to offering medical services. Infusion solutions and consumables, cleaning products, infusion pumps and systems, nutrition and pain management, suture materials, hip and knee implants, surgical instruments, dialysis equipment and accessories, ostomy care, and wound care products are some of the company's main offerings. In the areas of anaeanesthesiatracorporeal blood transfusion, intensive care, cardiology, and surgery, B. Braun offers goods and systems. Additionally, it provides services for medical practpracticesnics, and the home care industry. Europe, the Americas, Asia-Pacific, Africa, and the Middle East are all regions where the corporation offers its goods. The headquarters of B. Braun are iiselsungen, Germany. In June 2023, B. Braun Medical Inc. ("B. Braun"), a pioneer in renal therapy that includes cutting-edge, high-quality solutions for hemodialysis, and Rockwell Medical, Inc. announced that the two parties have agreed into atoee-year co-promotion services agreement
A medical technology firm called Medtronic Plc (Medtronic), originally known as Medtronic Inc., creates, develops, produces, and sells medical products. It provides products for the treatment of conditions such heart as valve issues, heart failure, aortic, peripheral vascular, venous renal, and neurological problems, as well as spine and musculoskeletal issues, ear, nose, and throat conditions. Additionally, it offers biologic solutions for the dental and orthopedicets. In Asia Pacific, Europe, the Americas, the Middle East, and Africa, it provides its products to hospitals, third-party healthcare providers, clinics, institand utions, including governmental healthcare prprogramsdistributors, and group purchasing orgaorganizationse headquarters of Medtronic are isDublin, Ireland. In August 2020, The InterStim Micro neurostimulator for sacral neuromodulation (SNM) therapy has recently received FDA approval, according to Medtronic plc, the world leader in medical technology, which recently made the announcement. The novel device was implanted into a patient for the first time at Cleveland Clinic.
June 2023: DoseTrac Enterprise Infusion Management Software, the company's new generation of infusion management software, has been released, according to B. Braun Medical Inc. (B. Braun). To better understand their infusion pump fleet and related data, orgaorganizations use a combination of real-time views and retrospective reporting options provided by this new software. With just one application, the DoseTrac Enterprise Software platform can also connect up to 40,000 pumps at an unlimited number of sites.
April 2022: The Crohn's and Colitis Foundation provided project funding to Microbiotica as a part of their inflammatory bowel disease ventures progrprogramthe creation of inflammatory bowel disease treatments.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 1.6 Billion |
| Market Size 2023 | USD 1.66 Billion |
| Market Size 2032 | USD 2.19 Billion |
| Compound Annual Growth Rate (CAGR) | 3.60% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Patient Type, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Coloplast, Medtronic Inc., 3M, B.Braun, C.R. Bard, Consure Medical, Cogentix Medical, Aquaflush Medical Ltd. |
| Key Market Opportunities | Developing healthcare facilities |
| Key Market Dynamics | Increasing spread of bowel disorders |
Frequently Asked Questions (FAQ) :
The Bowel Management Systems Market size was valued at USD 1.6 Billion in 2022.
The market is projected to grow at a CAGR of 3.60% during the forecast period, 2023-2032.
North America had the largest share of the market
The key players in the market are Coloplast, Medtronic Inc., 3M, B.Braun, C.R. Bard, Consure Medical, Cogentix Medical, Aquafland ush Medical Ltd.
The colostomy bags category dominated the market in 2022.
The home-care had the largest share of the market.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
